Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Federal Trade Commission
Medtronic
McKesson
Accenture
QuintilesIMS
Mallinckrodt
Dow

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,508,306

« Back to Dashboard

Title: Aromatic amine derivatives
Abstract:This invention relates to novel aromatic amine compounds having the structure: ##STR1## where each W, Z.sup.1 and Z.sup.2 is independently H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, F, Cl, Br, I, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; where each R.sup.1 and R.sup.2 is independently H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; where each X and Y is independently CH.sub.2, NR.sup.4, S, S.dbd.O, SO.sub.2 ; where n is 0, 1 or 2; where each p and q is independently 1 or 2; where R.sup.3 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; where R.sup.4 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or COR.sup.3 ; and where R.sup.5 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl, C.sub.1 -C.sub.6 straight or branched chain alkoxy or OH. In addition the invention includes using such compounds for the treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis.
Inventor(s): Chiu; George (Bridgewater, NJ), Gluchowski; Charles (Wayne, NJ)
Assignee: Synaptic Pharmaceutical Corporation (Paramus, NJ)
Filing Date:Sep 09, 1993
Application Number:08/124,501
Claims:1. A compound having the structure: ##STR139## wherein each W and Z.sup.1 is independently H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, F, Cl, Br, I, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; wherein Z.sup.2 is C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, F, Cl, Br, I, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; wherein each R.sup.1 and R.sup.2 is independently H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein X and Y are CH.sub.2 ; wherein n is 0, 1 or 2; wherein each p and q is independently 1 or 2; wherein R.sup.3 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein R.sup.4 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or COR.sup.3 ; and wherein R.sup.5 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl, C.sub.1 -C.sub.6 straight or branched chain alkoxy or OH.

2. A compound having the structure: ##STR140## wherein each W and Z.sup.1 is independently H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; Z.sup.2 is C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; wherein each R.sup.1 and R.sup.2 is independently H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein X and Y are CH.sub.2 ; wherein n is 0, 1 or 2; wherein each p and q is independently 1 or 2; wherein R.sup.3 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein R.sup.4 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or COR.sup.3 ; and wherein R.sup.5 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl, C.sub.1 -C.sub.6 straight or branched chain alkoxy or OH.

3. The compound of claim 1, wherein W is H.

4. The compound of claim 1, wherein n is 1.

5. The compound of claim 1, wherein R.sup.1 and R.sup.2 are both H.

6. The compound of claim 1, wherein p is 1.

7. The compound of claim 1, wherein q is 2.

8. The compound of claim 1, wherein p is 1 and q is 2.

9. The compound of claim 1, wherein Z.sup.2 is OCH.sub.3 and Z.sup.1 is H.

10. The compound of claim 1 having the structure: ##STR141##

11. The compound of claim 1 having the structure: ##STR142##

12. The compound of claim 1 having the structure: ##STR143##

13. A composition comprising a therapeutically effective amount of the compound of claim 1 or 2 and a pharmaceutically acceptable carrier.

14. A method for treating benign prostatic hyperplasia in a subject which comprises administering to the subject an amount of a compound having the structure: ##STR144## wherein each W, Z.sup.1 and Z.sup.2 is independently H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, OH, F, Cl, Br, I, NO.sub.2, CN, SO.sub.2 NHR.sup.3, NR.sup.4.sub.2, CONR.sup.3.sub.2, COR.sup.5 ; wherein each R.sup.1 and R.sup.2 is independently H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein each X and Y is independently CH.sub.2, NR.sup.4, C.dbd.O, S, S.dbd.O, SO.sub.2 ; wherein n is 0, 1 or 2; wherein each p and q is independently 1 or 2; wherein R.sup.3 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl; wherein R.sup.4 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or COR.sup.3 ; and wherein R.sup.5 is H, C.sub.1 -C.sub.6 straight or branched chain alkyl or phenyl, C.sub.1 -C.sub.6 straight or branched chain alkoxy or OH.

15. A method for treating benign prostatic hyperplasia in a subject which comprises administering to the subject an amount of a compound having the structure of claim 1.

16. A method for treating benign prostatic hyperplasia in a subject which comprises administering to the subject an amount of a compound having the structure of claim 2.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Harvard Business School
Accenture
Julphar
US Department of Justice
Daiichi Sankyo
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.